US 9149475
Protein kinase C inhibitors and uses thereof
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 9149475 (Protein kinase C inhibitors and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/538, A61K31/55